Ambroxol Hydrochloride

Form: Tablets, Syrup & Oral drops

Strength: Tab: 30 mg, 60 mg; Syrup: 15 mg/5 mL, 30 mg/5 mL; Drops: 7.5 mg/mL, 15 mg/mL

Reference Brands: Mucosolvan®, Flavamed®, Ambrobeta®, Ambroxol-ratiopharm®(EU)

Category: Respiratory Disorder

Ambroxol Hydrochloride is a widely used mucolytic agent in the EU pharmaceutical market, known for its effectiveness in treating respiratory conditions such as bronchitis, COPD, and other mucus-related disorders. It works by thinning and loosening mucus in the airways, making it easier to cough out. Ambroxol HCl is available in various dosage forms including tablets (30 mg, 60 mg), capsules (75 mg), syrups (15 mg/5 mL, 30 mg/5 mL), drops, lozenges, and effervescent tablets. Popular brands include Mucosolvan®, Flavamed®, Ambrobeta®, and Bisolvon®. Ideal for B2B pharmaceutical trade, Ambroxol HCl is a top choice for global export and respiratory care markets.